V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015965 | 160013162 | 0 | 58.95 | null | 2018-12-15 | 2018-12-29 | STS Rhabdo VIT0910 Vinc Irinotecan | 02 | null | GEMCARBO | 101565750 |
| 160015971 | 160013164 | 0 | 69.9 | Neo-adjuvant (N) | 2018-05-17 | 2018-05-17 | EW EuroEwing 2012 Arm B IE | 02 | N | VAI | 101396540 |
| 160015972 | 160013165 | 0 | 84.6 | Palliative (P) | 2016-11-05 | 2016-11-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100960491 |
| 160015973 | 160013166 | 1.65 | 13.5 | Curative (C) | 2019-07-29 | 2019-07-29 | Ifosfamide | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100533153 |
| 160015976 | 160013167 | 1.5 | 11.5 | null | 2018-07-21 | 2018-07-21 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 101305792 |
| 160015979 | 160013168 | 1.5 | 80.9 | Curative (C) | 2017-09-26 | 2017-10-09 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | TRIAL | 101428360 |
| 160015985 | 160013169 | 1.62 | 74 | null | 2018-06-02 | 2018-06-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 101625524 |
| 160015987 | 160013170 | 0 | 39.1 | Curative (C) | 2016-12-18 | 2016-12-29 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | CONFIRM TRIAL | 100741713 |
| 160015988 | 160013171 | 1.56 | 22 | null | 2021-09-11 | 2021-09-11 | Rucaparib | 01 | null | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 101831133 |
| 160015993 | 160013172 | 1.62 | 61.2 | null | 2016-07-28 | 2016-08-23 | GEMCITABINE | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 100967298 |
| 160015996 | 160013173 | 1.7 | 18 | Palliative (P) | 2019-09-18 | 2019-09-20 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | PROMISE-MESO TRIAL | 100967871 |
| 160015998 | 160013174 | 1.58 | 17.8 | null | 2017-01-02 | 2017-01-05 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 100933905 |
| 160016000 | 160013175 | 1.61 | 20.7 | Curative (C) | 2016-09-15 | 2016-12-18 | Ifosfamide | 01 | N | STS RHABDO RMS 2005 VIN CYCLO | 101644512 |
| 160016004 | 160013176 | 1.61 | 54 | Palliative (P) | null | 2016-05-10 | ETOP 13-18 BEAT-meso Trial | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100927957 |
| 160016007 | 160013177 | 1.65 | 9.2 | null | 2016-03-13 | 2016-04-18 | IPILIMUMAB + NIVOLUMAB | Y | null | EW EUROEWING 99 : VACTI | 100885300 |
| 160016009 | 160013178 | 0 | 82.9 | Curative (C) | 2020-06-25 | 2020-06-26 | Gemcitabine day 1&8 | N | null | NB HRNBL-1 ISOTRETINOIN | 100356006 |
| 160016010 | 160013179 | 1.66 | 100.4 | null | 2020-11-16 | 2021-06-27 | EW EuroEwing 2012 Arm B IE | 01 | null | CONFIRM TRIAL | 100349193 |
| 160016013 | 160013180 | 0 | 61.2 | Curative (C) | null | 2021-11-05 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | IVADO | 101056904 |
| 160016014 | 160013181 | 1.6 | 2.3 | 03 | 2018-06-20 | 2018-06-21 | Cyclophosphamide + Topotecan | 02 | N | CYCLOPHOSPHAMIDE + DACTINOMYCIN + DOXORUBICIN + VINCRISTINE | 100521134 |
| 160016016 | 160013182 | 1.71 | 61 | Palliative (P) | 2016-07-28 | 2016-08-05 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | CISPLATIN + PACLITAXEL | 101728123 |
| 160016023 | 160013184 | 1.66 | 81.6 | Curative (C) | 2019-10-14 | 2020-04-27 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | PROMISE-MESO TRIAL | 101518178 |
| 160016026 | 160013185 | 1.84 | 57.2 | null | 2018-10-31 | 2018-12-19 | Dacarbazine | 02 | null | PEMBROLIZUMAB | 101127842 |
| 160016031 | 160013186 | 0 | 72.2 | Curative (C) | 2020-01-08 | 2020-01-14 | GEMCITABINE | 02 | N | OLAPARIB | 100087288 |
| 160016033 | 160013187 | 0 | 62.1 | Palliative (P) | 2017-06-04 | 2017-08-23 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | OLAPARIB | 101320679 |
| 160016035 | 160013188 | 0 | 16.7 | Palliative (P) | 2019-08-26 | 2019-10-07 | Etoposide oral | 02 | N | CAPECITABINE | 101466082 |
| 160016036 | 160013189 | 1.64 | 18 | null | 2021-12-18 | 2021-12-22 | Bevacizumab+Carbo+Pacliaxel | 02 | null | POMALIDOMIDE | 100744831 |
| 160016037 | 160013190 | null | 89.3 | Curative (C) | 2018-06-29 | 2018-07-10 | Larotrectinib | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100627735 |
| 160016038 | 160013191 | null | 54 | Curative (C) | 2017-11-12 | 2017-11-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | VINCRISTINE | 101849043 |
| 160016039 | 160013192 | null | 46 | Palliative (P) | 2016-09-29 | 2016-09-29 | IVA | 02 | N | IFOSFAMIDE | 101522556 |
| 160016044 | 160013193 | 1.78 | 64 | Curative (C) | 2017-08-17 | 2017-08-17 | Venetoclax | 02 | N | GEMCITABINE | 101273053 |
| 160016045 | 160013194 | 1.67 | 21.6 | Curative (C) | null | 2018-06-06 | Doxorubicin + Ifosfamide | 02 | N | OLAPARIB | 100837130 |
| 160016052 | 160013195 | 1.83 | 98.7 | Neo-adjuvant (N) | 2018-03-15 | 2018-07-20 | STS Rhabdo RMS 2005 Vin Cyclo | Y | N | GEMCITABINE | 100469429 |
| 160016053 | 160013196 | 0 | 58.3 | null | 2016-05-10 | 2017-01-23 | Cyclophosphamide High Dose | 02 | null | EW EUROEWING 2012 ARM B IE | 100007149 |
| 160016054 | 160013197 | null | null | null | 2019-08-02 | 2019-09-02 | Doxorubicin + Ifosfamide | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101490712 |
| 160016059 | 160013198 | 0.8 | 57.3 | Palliative (P) | 2017-02-07 | 2017-03-03 | Bevacizumab+Carbo+Pacliaxel | 02 | N | PAZOPANIB | 101423964 |
| 160016071 | 160013199 | 1.56 | null | Curative (C) | 2019-08-06 | 2019-10-09 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 101610285 |
| 160016072 | 160013200 | 0 | 56.6 | null | null | 2017-11-15 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 100999312 |
| 160016074 | 160013201 | 1.63 | 16 | null | 2018-09-13 | 2018-09-27 | null | 02 | null | IFOSFAMIDE | 100243673 |
| 160016079 | 160013202 | 1.61 | 52 | Curative (C) | 2017-06-15 | 2017-06-18 | ETOP 13-18 BEAT-meso Trial | N | N | DOXORUBICIN + IFOSFAMIDE | 101778619 |
| 160016081 | 160013203 | 0 | 18.5 | null | 2019-12-07 | 2019-12-07 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | OLARATUMAB | 101388009 |
| 160016093 | 160013205 | 1.72 | 87.35 | Neo-adjuvant (N) | 2019-10-13 | 2019-10-28 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | RUCAPARIB | 100958463 |
| 160016095 | 160013206 | 1.82 | 96.75 | Curative (C) | 2016-04-28 | 2016-04-30 | NB BEACON Temozolomide alone | 02 | N | EW EUROEWING 2012 ARM B VDC | 100282253 |
| 160016097 | 160013207 | null | null | Palliative (P) | 2017-07-06 | 2017-07-06 | Ifosfamide | null | N | IFOSFAMIDE | 101123853 |
| 160016100 | 160013208 | 1.6 | 78.5 | Neo-adjuvant (N) | 2018-08-17 | 2018-12-08 | EW EuroEwing 2012 Arm B VC | 02 | N | NOT MATCHED | 100759151 |
| 160016101 | 160013209 | 1.83 | 74 | null | 2019-01-15 | 2019-02-04 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | IPILIMUMAB + NIVOLUMAB | 101733720 |
| 160016102 | 160013210 | 1.69 | 14.1 | null | 2019-05-28 | 2019-05-30 | GEMCITABINE | 02 | null | EW EUROEWING 2012 ARM B VDC | 100224260 |
| 160016107 | 160013211 | null | 114.6 | null | 2017-09-03 | 2018-04-19 | Cyclophosphamide + Vincristine | 02 | null | ABIRATERONE | 101313962 |
| 160016118 | 160013212 | 1.75 | 36.2 | null | 2020-04-04 | 2020-04-17 | Ifosfamide 3g/m2 5 day | 02 | null | IVA | 101008628 |
| 160016120 | 160013213 | 1.77 | 69.9 | Curative (C) | 2018-11-22 | 2018-12-06 | ETOP 13-18 BEAT-meso Trial | 01 | N | EW EUROEWING 2012 ARM B VC | 101614220 |
| 160016121 | 160013214 | 1.84 | 57.7 | null | 2018-07-28 | 2018-08-08 | Cyclophosphamide PO +Vinorelbine IV | 02 | null | RUCAPARIB | 100093224 |